US Stocks
/
Krystal Biotech, Inc. Share Price

Krystal Biotech, Inc. Share Price

NASDAQ: KRYS | Mid Cap
$336.59
-$2.54 (-0.75%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Krystal Biotech, Inc. Stock Performance

Open
$338.46
Prev. Close
$339.13
Circuit Range
N/A
Day Range
$335.91 - $340.04
Year Range
$155.48 - $382.01
Volume
10,886
Average Traded
$337.40

Krystal Biotech, Inc. Share Price Today

As of 19 September 2026, Krystal Biotech, Inc.'s share price is $336.59. The stock opened at $338.46, compared to its previous close of $339.13. During today's trading session, Krystal Biotech, Inc.'s share price traded between $335.91 and $340.04, with an average price of $337.98. Over the past 52 weeks, the stock has recorded a high of $382.01 and a low of $155.48. In terms of performance, Krystal Biotech, Inc.'s share price has risen by 30.56% over the last six months and is up 90.57% on a year-on-year basis.

Krystal Biotech, Inc. Share Price Chart

$335.91$340.04
L
Show Current Price
H

Krystal Biotech, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.74B
PE Ratio (TTM)
47.54
Dividend Yield
N/A
EPS (TTM)
$7.08
Revenue (TTM)
$389.13M
Return On Equity (TTM)
16.80%
Profit Margin
52.64%
Debt to Equity
0.08
Quarterly Earnings Growth YoY
N/A

Krystal Biotech, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024
Revenue$45.25M$70.28M$83.84M
Net Profit$932000.00$15.57M$27.18M
Net Profit Margin2.06%22.15%32.42%
Income ChangeN/A1570.39%74.59%

About Krystal Biotech, Inc.

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Krystal Biotech, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$360.80
$336.74
-5.80%
Aug 2026
$322.00
$357.49
+4.81%
Jul 2026
$369.77
$341.08
-8.25%
Jun 2026
$306.16
$371.74
+20.25%
May 2026
$263.03
$309.14
+17.80%
Apr 2026
$258.50
$262.42
+1.79%
Mar 2026
$267.50
$257.81
-6.37%
Feb 2026
$279.99
$275.35
-1.38%
Jan 2026
$245.06
$279.19
+12.87%
Dec 2025
$213.98
$247.35
+13.87%
Nov 2025
$196.15
$217.22
+10.23%
Oct 2025
$179.13
$197.06
+11.57%

KRYS Share Price FAQs

What is Krystal Biotech, Inc. share price today?

chevron-up
Krystal Biotech, Inc. share price today is $336.59 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Krystal Biotech, Inc. stock?

chevron-up
The 52 week high of Krystal Biotech, Inc. stock is $382.01, while the 52 week low is $155.48 as of 19 Sep '26.

What is KRYS's market capitalisation today?

chevron-up
KRYS market capitalisation is $9.74B as of September 19, 2026, at 10:39 pm IST.

What is KRYS's net income for the last quarter?

chevron-up
KRYS's net income for the last quarter is 0.03B USD.

What is the 5 year returns of KRYS?

chevron-up
The 5 year returns of KRYS is 544.68% as on 19 Sep '26.

What is the high & low stock price of KRYS today?

chevron-up
KRYS stock price hit a high of $340.04 and low of $335.91 as of 19 Sep '26.

Can I buy KRYS shares in India?

chevron-up
Yes. You can buy KRYS in India by opening an international trading account.